Skip to main content
Clinical Trials/CTRI/2015/06/005842
CTRI/2015/06/005842
Completed
Phase 4

Comparative evaluation of propofol-fentanyl, propofol-midazolam and propofol-dexmedetomidine on haemodynamic and postoperative recovery for endoscopic retrograde cholangiopancreatography: A prospective, randomized controlled study

Apollo Hospitals Bilaspur0 sites93 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: null- ASA grade I or III patient, Non diabetic, Non hypertensive and require Endoscopic retrograde cholangiopancreatography
Sponsor
Apollo Hospitals Bilaspur
Enrollment
93
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • ASA grade I and III

Exclusion Criteria

  • 1\.Patients with known sensitivity to study drugs
  • 2\.History of drug or alcohol abuse,
  • 3\.Morbid obesity (body mass index \>40\),
  • 4\.History of chronic pain or daily intake of analgesics
  • 5\.Oral anticoagulant use (warfarin)
  • 6\.Patients with bleeding diathesis
  • 7\.Impaired kidney or endocrinal functions
  • 8\.Pregnant patients and
  • 9\.Psychiatric patients

Outcomes

Primary Outcomes

Not specified

Similar Trials